VAMP2 and central nervous system cancer: QRT-PCR assay showed that VAMP2 mRNA was gradually decreased with the increase of WHO grades, and that it reached the lowest level in WHO 4 gliomas compared to normal tissues (Figure 6A), while VAMP5 mRNA showed the opposite changes (Figure 6B).